000 | 01975 a2200505 4500 | ||
---|---|---|---|
005 | 20250517134506.0 | ||
264 | 0 | _c20170818 | |
008 | 201708s 0 0 eng d | ||
022 | _a1529-2401 | ||
024 | 7 |
_a10.1523/JNEUROSCI.2911-16.2017 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKhomula, Eugen V | |
245 | 0 | 0 |
_aSexual Dimorphism in a Reciprocal Interaction of Ryanodine and IP _h[electronic resource] |
260 |
_bThe Journal of neuroscience : the official journal of the Society for Neuroscience _c02 2017 |
||
300 |
_a2032-2044 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDinoprostone _xadverse effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGanglia, Spinal _xcytology |
650 | 0 | 4 |
_aHyperalgesia _xchemically induced |
650 | 0 | 4 |
_aInositol 1,4,5-Trisphosphate _xpharmacology |
650 | 0 | 4 |
_aInositol 1,4,5-Trisphosphate Receptors _xantagonists & inhibitors |
650 | 0 | 4 |
_aMacrocyclic Compounds _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOligodeoxyribonucleotides, Antisense _xpharmacology |
650 | 0 | 4 |
_aOxazoles _xpharmacology |
650 | 0 | 4 | _aPain Measurement |
650 | 0 | 4 |
_aPain Threshold _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRyanodine _xadverse effects |
650 | 0 | 4 |
_aRyanodine Receptor Calcium Release Channel _xmetabolism |
650 | 0 | 4 |
_aSensory Receptor Cells _xdrug effects |
650 | 0 | 4 | _aSex Characteristics |
650 | 0 | 4 |
_aThapsigargin _xpharmacology |
700 | 1 | _aFerrari, Luiz F | |
700 | 1 | _aAraldi, Dionéia | |
700 | 1 | _aLevine, Jon D | |
773 | 0 |
_tThe Journal of neuroscience : the official journal of the Society for Neuroscience _gvol. 37 _gno. 8 _gp. 2032-2044 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1523/JNEUROSCI.2911-16.2017 _zAvailable from publisher's website |
999 |
_c26811292 _d26811292 |